|
ATCC
t 24 ![]() T 24, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc05286817-43-17-23?v=ATCC Average 98 stars, based on 1 article reviews
t 24 - by Bioz Stars,
2026-08
98/100 stars
|
Buy from Supplier |
|
BioResource International Inc
human bladder cancer cell lines t24 (p53-mutant) ![]() Human Bladder Cancer Cell Lines T24 (P53 Mutant), supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pm28498480-24-0-15?v=BioResource+International+Inc Average 90 stars, based on 1 article reviews
human bladder cancer cell lines t24 (p53-mutant) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
BioResource International Inc
human bladder cancer cell lines tsgh-8301 (wild-type p53) ![]() Human Bladder Cancer Cell Lines Tsgh 8301 (Wild Type P53), supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pm28498480-24-8-15?v=BioResource+International+Inc Average 90 stars, based on 1 article reviews
human bladder cancer cell lines tsgh-8301 (wild-type p53) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Biotium
cd7(t3-3a1) ![]() Cd7(t3 3a1), supplied by Biotium, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/custom%40bnc040978-100%40us07759479?v=Biotium Average 93 stars, based on 1 article reviews
cd7(t3-3a1) - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
ATCC
mutant p53 ![]() Mutant P53, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc00024283-124-298-307?v=ATCC Average 99 stars, based on 1 article reviews
mutant p53 - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
ATCC
caption a7 ![]() Caption A7, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc00024283-124-23-37?v=ATCC Average 96 stars, based on 1 article reviews
caption a7 - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
ATCC
source bhk atcc ψ2 retroviral packaging atcc pa317 retroviral packaging atcc pa shd pa317 packaging control virus lxshd ![]() Source Bhk Atcc ψ2 Retroviral Packaging Atcc Pa317 Retroviral Packaging Atcc Pa Shd Pa317 Packaging Control Virus Lxshd, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/human+bladder+cancer+cell+lines+t24+%28p53-mutant%29/pmc00024283-124-35-37?v=ATCC Average 95 stars, based on 1 article reviews
source bhk atcc ψ2 retroviral packaging atcc pa317 retroviral packaging atcc pa shd pa317 packaging control virus lxshd - by Bioz Stars,
2026-08
95/100 stars
|
Buy from Supplier |
Image Search Results
Journal: BMC Cancer
Article Title: The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells
doi: 10.1186/s12885-017-3085-z
Figure Lengend Snippet: Effect of p53 silencing on cytotoxicity of FrA. a , b Western blotting analysis of p53 expression in RT112 cells treated with FrA for 48 h ( a ) or transfected with p53 siRNA versus cells transfected with scrambled siRNA ( b ). c Viability of transfected cells treated with FrA or Cis for 48 h. Cell viability was analyzed by flow cytometry analysis using annexin-V-FITC/PI double staining. Viable cells appearing in the lower left quadrant were quantified using the Cell Quest Pro software. d , e Effect of pifithrin-α (Pif-α)–an inhibitor of p53 activity–on the cytotoxic activity of FrA and Cis in nontransfected RT112 cells. Cells were pretreated with 40 μM of Pif-α for 30 min and then cotreated with FrA ( d ) or Cis ( e ) for 48 h. Cell viability was determined using MTT-assay
Article Snippet: The human urothelial cancer cell lines RT4 (p53 wild type), HT-1197 (p53 wild type), TCC-SUP (mutant p53),
Techniques: Western Blot, Expressing, Transfection, Flow Cytometry, Double Staining, Software, Activity Assay, MTT Assay
Journal:
Article Title: The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments
doi:
Figure Lengend Snippet: Information about cell lines
Article Snippet: Cells were obtained from subconfluent cultures, and colonies were scored 14–21 days later ( 20 ). table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Designate Parental line Related characteristics and transgene expression Reference or source BHK ATCC Ψ2 Retroviral packaging ATCC PA317 Retroviral packaging ATCC PA/SHD PA317 Packaging control virus LXSHD This study PA/mR1 PA317 Packaging SHD/mR1 * virus This study SC2 L60 R2 is in excess as compared to R1 McClarty et al . ( 6 ) SC2/SHD SC2 his D † This study SC2/mR1 SC2 mR1, his D † This study CIRAS-1 10T½ T24 H- ras Egan et al . ( 25 ) C1/SHD CIRAS-1 his D † , T24 H- ras This study C1/mR1 CIRAS-1 mR1 * , his D † , T24 H- ras This study C1/mR2 CIRAS-1 mR2 * , T24 H- ras Fan et al . ( 20 ) C1/mR2/SHD C1/mR2 his D † , mR2 * , T24 H- ras This study C1/mR2/mR1 C1/mR2 mR1, his D † , mR2 * , T24 H- ras This study C1/mR2a/SHD C1/mR2a ‡ his D † , mR2 * , T24 H- ras This study C1/mR2a/mR1 C1/mR2a ‡ mR1 * , his D † , mR2 * , T24 H- ras This study ras-3 (or R-3) 10T½ T24 H- ras Taylor et al . ( 26 ) ras-3/SHD ras-3 his D † , T24 H- ras This study ras-3/mR1 ras-3 mR1 * , his D † , T24 H- ras This study RMP-6 10T½ T24 H- ras , c- myc , mutant p53 Taylor et al . ( 26 ) RMP/SHD RMP-6 his D † , T24 H- ras , c- myc ,
Techniques: Expressing, Mutagenesis
Journal:
Article Title: The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments
doi:
Figure Lengend Snippet: Information about cell lines
Article Snippet: Cells were obtained from subconfluent cultures, and colonies were scored 14–21 days later ( 20 ). table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Designate Parental line Related characteristics and transgene expression Reference or
Techniques: Expressing, Mutagenesis
Journal:
Article Title: The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments
doi:
Figure Lengend Snippet: Analysis of Myc-tagged R1 expression from pSHD/mR1 transiently transfected BHK cells by the indirect immunofluorescence assay (A), and from the stable retroviral packaging cell line PA/mR1 by radioimmunoprecipitation (B). Anti-Myc epitope antibody 9E10 was used for both assays.
Article Snippet: Cells were obtained from subconfluent cultures, and colonies were scored 14–21 days later ( 20 ). table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Designate Parental line Related characteristics and transgene expression Reference or
Techniques: Expressing, Transfection, Immunofluorescence